14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $9.96 $11.82 Friday, 3rd May 2024 FOLD stock ended at $10.40. This is 0.288% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.15% from a day low at $10.36 to a day high of $10.79.
90 days $9.96 $14.03
52 weeks $9.70 $14.57

Historical Amicus Therapeutics prices

Date Open High Low Close Volume
May 04, 2023 $12.01 $12.01 $11.62 $11.85 1 725 807
May 03, 2023 $11.63 $12.12 $11.50 $12.06 2 556 277
May 02, 2023 $11.83 $11.88 $11.52 $11.55 1 576 861
May 01, 2023 $11.54 $11.91 $11.49 $11.90 1 701 508
Apr 28, 2023 $11.36 $11.80 $11.28 $11.54 1 856 705
Apr 27, 2023 $11.56 $11.66 $11.38 $11.40 1 065 340
Apr 26, 2023 $11.48 $11.84 $11.41 $11.56 2 099 804
Apr 25, 2023 $11.45 $11.55 $11.33 $11.55 1 174 017
Apr 24, 2023 $11.38 $11.58 $11.26 $11.49 1 148 407
Apr 21, 2023 $11.51 $11.63 $11.33 $11.45 1 171 018
Apr 20, 2023 $11.60 $11.63 $11.42 $11.50 1 277 861
Apr 19, 2023 $11.83 $11.88 $11.66 $11.68 1 083 988
Apr 18, 2023 $11.87 $11.94 $11.64 $11.89 2 048 840
Apr 17, 2023 $11.49 $11.93 $11.45 $11.87 2 798 388
Apr 14, 2023 $11.56 $11.77 $11.28 $11.40 1 081 312
Apr 13, 2023 $11.08 $11.68 $11.01 $11.59 1 753 933
Apr 12, 2023 $11.26 $11.26 $11.03 $11.05 898 314
Apr 11, 2023 $11.14 $11.29 $11.09 $11.20 1 444 974
Apr 10, 2023 $11.16 $11.23 $10.99 $11.08 1 582 254
Apr 06, 2023 $11.11 $11.23 $11.00 $11.22 2 310 961
Apr 05, 2023 $10.89 $11.10 $10.87 $11.06 1 316 311
Apr 04, 2023 $11.28 $11.36 $10.90 $10.93 1 784 171
Apr 03, 2023 $11.13 $11.34 $11.05 $11.26 1 429 388
Mar 31, 2023 $11.03 $11.21 $11.00 $11.09 2 202 503
Mar 30, 2023 $11.22 $11.29 $10.80 $10.91 2 517 631
Click to get the best stock tips daily for free!

About Amicus Therapeutics

Amicus Therapeutics Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. It also develops AT-GAA, a novel treatment paradigm for Pompe disease; enzym... FOLD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT